Does APIXABAN Cause Intentional product use issue? 2,874 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 2,874 reports of Intentional product use issue have been filed in association with APIXABAN (ELIQUIS). This represents 1.8% of all adverse event reports for APIXABAN.
2,874
Reports of Intentional product use issue with APIXABAN
1.8%
of all APIXABAN reports
226
Deaths
845
Hospitalizations
How Dangerous Is Intentional product use issue From APIXABAN?
Of the 2,874 reports, 226 (7.9%) resulted in death, 845 (29.4%) required hospitalization, and 198 (6.9%) were considered life-threatening.
Is Intentional product use issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for APIXABAN. However, 2,874 reports have been filed with the FAERS database.
What Other Side Effects Does APIXABAN Cause?
Death (18,501)
Cerebrovascular accident (7,237)
Atrial fibrillation (5,690)
Off label use (5,590)
Thrombosis (5,298)
Fall (5,063)
Cardiac disorder (4,917)
Haemorrhage (4,770)
Dyspnoea (4,379)
Gastrointestinal haemorrhage (4,030)
What Other Drugs Cause Intentional product use issue?
INFLIXIMAB (11,028)
RITUXIMAB (9,602)
INFLIXIMAB-DYYB (7,549)
TOCILIZUMAB (5,078)
METHOTREXATE (4,087)
PREDNISONE (3,961)
ABATACEPT (3,693)
ADALIMUMAB (3,557)
NIVOLUMAB (3,297)
LEFLUNOMIDE (3,280)
Which APIXABAN Alternatives Have Lower Intentional product use issue Risk?
APIXABAN vs APOMORPHINE
APIXABAN vs APRACLONIDINE
APIXABAN vs APREMILAST
APIXABAN vs APREPITANT
APIXABAN vs APROTININ